Assenagon Asset Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,224
Closed -$745K 1160
2025
Q4
$745K Buy
+5,224
New +$700K ﹤0.01% 995
2024
Q3
Sell
-10,109
Closed -$1.2M 1405
2024
Q2
$1.2M Sell
10,109
-18,408
-65% -$1.94M ﹤0.01% 1049
2024
Q1
$3.06M Buy
+28,517
New +$2.84M 0.01% 738
2020
Q4
Sell
-7,149
Closed -$1.31M 1129
2020
Q3
$1.31M Sell
7,149
-68,914
-91% -$13M 0.01% 702
2020
Q2
$14M Buy
+76,063
New +$15.1M 0.09% 142
2018
Q4
Sell
-18,046
Closed -$5.1M 1064
2018
Q3
$5.1M Buy
+18,046
New +$5.29M 0.05% 296

Other funds holding ICUI

Assenagon Asset Management's ICUI Position: Q1 2026 in Review

Assenagon Asset Management sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 5,224 shares — an estimated $745K sold.

Assenagon Asset Management first reported a position in ICUI in Q3 2018 and held it in 6 quarters. The position peaked at $14M in Q2 2020. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Assenagon Asset Management reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 5,224 ICU Medical shares in Q1 2026, an estimated $745K.
  • Assenagon Asset Management first reported a position in ICU Medical in Q3 2018 and held it in 6 quarters.
  • Assenagon Asset Management's ICU Medical position peaked at $14M in Q2 2020.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.